SCHEMBL8737447

SCHEMBL8737447

N#Cc1cc(N=O)ccc1N1CCNCC1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.48
ROCK2 O75116 1/20 0.47
ROCK1 Q13464 1/20 0.47
CDC42BPB Q9Y5S2 1/20 0.47
DRD2 P14416 1/20 0.43
DRD3 P35462 1/20 0.43
LMNA P02545 1/20 0.42
DPP4 P27487 1/20 0.40
HTR6 P50406 4/20 0.40
AR P10275 1/20 0.40
BMPR1B O00238 2/20 0.39
BMPR1A P36894 2/20 0.39
ACVR1B P36896 2/20 0.39
ACVRL1 P37023 2/20 0.39
ACVR1 Q04771 2/20 0.39
CDC7 O00311 1/20 0.39
PIM1 P11309 1/20 0.39
CDK9 P50750 1/20 0.39
OPRL1 P41146 1/20 0.39
NCF1 P14598 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14035954 0.83 MAPK1 (0.51) ALDH1A1ROCK2ROCK1CDC42BPBLMNA
SCHEMBL8736858 0.79 MAPT (0.43) ALDH1A1LMNAOPRL1HTR3EHTR3B
SCHEMBL8737585 0.79 HTR3A (0.56) ALDH1A1HTR6HTR3EHTR3BCYP1A2
SCHEMBL3636287 0.78 GAA (0.56) ALDH1A1ROCK2ROCK1CDC42BPBDRD2
SCHEMBL20883839 0.78 HTR3A (0.52) ALDH1A1ROCK2ROCK1CDC42BPBDRD2
SCHEMBL654285 0.78 ALDH1A1 (0.57) ALDH1A1ROCK2ROCK1CDC42BPBDRD2
SCHEMBL2997329 0.78 ALDH1A1 (0.57) ALDH1A1ROCK2ROCK1CDC42BPBDRD2
Hydrochloric Acid SCHEMBL23302956 0.76 ALDH1A1 (0.56) ALDH1A1ROCK2ROCK1CDC42BPBDRD2
Hydrochloric Acid SCHEMBL29882494 0.76 ALDH1A1 (0.56) ALDH1A1ROCK2ROCK1CDC42BPBDRD2
SCHEMBL28239107 0.76 NCF1 (0.45) ALDH1A1NCF1HTR3EHTR3BHTR1D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120129870-A1 PIPERAZINYL DERIVATIVES USEFUL AS MODULATORS OF THE NEUROPEPTIDE Y2 RECEPTOR JANSSEN PHARMACEUTICA NV (BE) 2012-05-24 US disclosed
US-20090099199-A1 ORGANIC COMPOUNDS NOVARTIS AG (CH) 2009-04-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120129870-A1 PIPERAZINYL DERIVATIVES USEFUL AS MODULATORS OF THE NEUROPEPTIDE Y2 RECEPTOR NPY2R, NPY1R, NPY5R ALDH1A1 4338/4885ROCK2 263/4885ROCK1 749/4885
US-20090099199-A1 ORGANIC COMPOUNDS SLCO4C1, SLC10A6, SLCO1B1 ALDH1A1 47/4885ROCK2 3971/4885ROCK1 2941/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.